Castle Biosciences, Inc.
- CSTL
- NASDAQ
- Medical - Diagnostics & Research
- Dermatology Diagnostics
- Prognostic Gene Expression Tests
- Cancer Diagnostics (Melanoma)
$31.96
Today −5.44%Quote Oct 16, 2026, 08:00 PM UTC
−13.10%over the last month
Max drawdown −13.1%From 1-month high −13.1%3 months +33.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$976.4M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$39.00
+22.0% from here
Floor
$31.78
0.6% below price
Where the price sits
11 analysts
Analyst range, low to high
$35.00$44.00
- Price $31.96
- Resistance $32.19–$32.51
- Consensus $39.00
The price is just above its floor and right under resistance. Analysts' average target sits about 22% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CSTLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Diagnostics & Research
Employees
1,002